List of articles with "Parkinson's Disease"

New Era in Parkinson's

New Era in Parkinson's

USA New York Parkinson's Disease Olatec Therapeutics Dapansutrile
Moving Day Walks 2026

Moving Day Walks 2026

USA Parkinson's Disease Various Cities Parkinson's Foundation Moving Day
ASPIRO Trial Updates

ASPIRO Trial Updates

USA San Diego Parkinson's Disease Aspen Neuroscience Sasineprocel
Parkinson's Research Support

Parkinson's Research Support

United States Washington, D.C. Parkinson's Disease Research Funding paraquat
Innovative Parkinson's Therapy

Innovative Parkinson's Therapy

United States San Diego Parkinson's Disease Aspen Neuroscience Sasineprocel
Parkinson's Therapy Growth

Parkinson's Therapy Growth

Israel Parkinson's Disease biotechnology NESS ZIONA Matricelf Ltd.
Groundwater and Parkinson's

Groundwater and Parkinson's

United States Minneapolis Parkinson's Disease Health Risks Groundwater
Parkinson's IQ + You Event

Parkinson's IQ + You Event

United States Parkinson's Disease Henderson Michael J. Fox Foundation Henderson NV
Transforming Parkinson's Care

Transforming Parkinson's Care

USA New York Parkinson's Disease Patient Care Parkinson's Foundation
Parkinson's IQ + You

Parkinson's IQ + You

United States Parkinson's Disease community support Michael J. Fox Henderson, St. Louis, Dallas-Fort Worth, Washington D.C.
Milestones in Parkinson's Therapy

Milestones in Parkinson's Therapy

United States San Diego Parkinson's Disease Aspen Neuroscience ANPD001
Aspen Neuroscience Leadership Changes

Aspen Neuroscience Leadership Changes

USA San Diego Parkinson's Disease Aspen Neuroscience Revati Shreeniwas
Parkinson's Therapy Grant

Parkinson's Therapy Grant

USA San Diego Parkinson's Disease Kenai Therapeutics RNDP-001
Kenai Initiates RNDP-001 Trial

Kenai Initiates RNDP-001 Trial

USA San Diego Parkinson's Disease Kenai Therapeutics RNDP-001
Parkinson's Drug Targets

Parkinson's Drug Targets

United States Parkinson's Disease Sacramento Lunai Bioworks AI therapeutics
Exercise and Aging

Exercise and Aging

USA New York Parkinson's Disease NYU Langone Dopamine Release
MJFF Targets Initiative

MJFF Targets Initiative

United States New York Parkinson's Disease Michael J. Fox Treatment Targets
RLS and Parkinson's Risk

RLS and Parkinson's Risk

South Korea Seoul Parkinson's Disease RLS Dopamine Treatment
Age-Friendly Hospitals

Age-Friendly Hospitals

USA Parkinson's Disease Age-Friendly Care Parkinson's Foundation New York and Miami
Genetic Research Breakthrough

Genetic Research Breakthrough

United States Washington Parkinson's Disease MJFF Global Genetics Program
Queen Square Podcast

Queen Square Podcast

London United Kingdom Parkinson's Disease Essential Tremor Queen Square Imaging
Funding for Aspen Neuroscience

Funding for Aspen Neuroscience

USA San Diego Parkinson's Disease Aspen Neuroscience ANPD001
CND's Syn-One in Parkinson's Trials

CND's Syn-One in Parkinson's Trials

United States Scottsdale Parkinson's Disease CND Life Sciences Syn-One
2026 Community Grants Open

2026 Community Grants Open

USA New York Parkinson's Disease Community Grants Parkinson's Foundation
Parkinson's Podcast Awards

Parkinson's Podcast Awards

United States New York Parkinson's Disease Michael J. Fox Signal Awards
Texas Voters Approve Funding

Texas Voters Approve Funding

USA Texas Parkinson's Disease Michael J. Fox Foundation Proposition 14
APDA Bridge Funding Awards

APDA Bridge Funding Awards

United States New York Parkinson's Disease Research Funding APDA
CND Life Sciences NIH Grant

CND Life Sciences NIH Grant

United States Scottsdale Parkinson's Disease CND Life Sciences Essential Tremor
Breakthrough in Parkinson's

Breakthrough in Parkinson's

China Shanghai Parkinson's Disease UniXell Biotech UX-DA001
MTX325 Parkinson's Funding

MTX325 Parkinson's Funding

Cambridge United Kingdom Parkinson's Disease Mission Therapeutics MTX325
Clario & Oxford Revolutionize Research

Clario & Oxford Revolutionize Research

USA Philadelphia Parkinson's Disease Clario Opal Sensor
Loneliness and Parkinson's

Loneliness and Parkinson's

USA Honolulu Parkinson's Disease Loneliness Motor Decline
Cycling Slows Parkinson's

Cycling Slows Parkinson's

USA Honolulu Parkinson's Disease aerobic cycling exercise intervention
Parkinson's Cell Therapy

Parkinson's Cell Therapy

USA Honolulu Parkinson's Disease Stem Cell Therapy dopaminergic neurons
New Findings on ND0612

New Findings on ND0612

USA Honolulu Parkinson's Disease ND0612 Mitsubishi Pharma
Neuropixels Unlocks Insights

Neuropixels Unlocks Insights

USA Denver Parkinson's Disease CU Anschutz Neuropixels
Cohort 3 Launch

Cohort 3 Launch

United States San Diego Parkinson's Disease Aspen Neuroscience ANPD001
Parkinson's Market Growth

Parkinson's Market Growth

USA Austin Parkinson's Disease Market Research Therapeutics
Michael J. Fox Award

Michael J. Fox Award

United States New York City Parkinson's Disease Michael J. Fox Galien Foundation
Continuous Flow Synthesis

Continuous Flow Synthesis

Parkinson's Disease 無し Safinamide Continuous Flow
New Funding for PD Research

New Funding for PD Research

USA New York Parkinson's Disease American Parkinson Disease Association APDA Grants
Excellence in Care Centers

Excellence in Care Centers

USA Parkinson's Disease New York, Miami Parkinson's Foundation Centers of Excellence
Parkinson's Disease Webinar

Parkinson's Disease Webinar

None Clinical Trials Parkinson's Disease Xtalks
Seal Rock's LRRK2 Partnership

Seal Rock's LRRK2 Partnership

USA Seattle Parkinson's Disease Seal Rock LRRK2
Promising Parkinson's Therapy

Promising Parkinson's Therapy

Taiwan Taipei Parkinson's Disease ENERGI-F705PD Energenesis
New Leadership at Parkinson's

New Leadership at Parkinson's

United States New York Parkinson's Disease Parkinson's Foundation Andi Lipstein Fristedt
New A9 Neurons for Research

New A9 Neurons for Research

United States Parkinson's Disease Trailhead Biosystems Beachwood A9 Neurons
Insights into Parkinson's

Insights into Parkinson's

USA Washington Parkinson's Disease Allen Institute Brain Research
New Leadership at Brenig

New Leadership at Brenig

USA Parkinson's Disease Brenig Therapeutics BT-267 Somerville, Massachusetts
FDA Approves Insightec's Treatment

FDA Approves Insightec's Treatment

USA Miami Parkinson's Disease Insightec Exablate Neuro

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.